BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27914569)

  • 1. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
    Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
    Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
    Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
    J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
    Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
    Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer.
    Freyer G; You B; Villet S; Tartas S; Fournel-Federico C; Trillet-Lenoir V; Hamizi S; Colomban O; Chavernoz N; Falandry C
    Homeopathy; 2014 Oct; 103(4):232-8. PubMed ID: 25439039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of arthritis in rats by Toxicodendron pubescens and its homeopathic dilutions.
    Patil CR; Rambhade AD; Jadhav RB; Patil KR; Dubey VK; Sonara BM; Toshniwal SS
    Homeopathy; 2011 Jul; 100(3):131-7. PubMed ID: 21784329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
    Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
    Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
    Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
    J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital clinical trial: Homeopathy (Agraphis nutans 5CH, Thuya occidentalis 5CH, Kalium muriaticum 9CH and Arsenicum iodatum 9CH) as adjuvant, in children with otitis media with effusion.
    Pedrero-Escalas MF; Jimenez-Antolin J; Lassaletta L; Diaz-Saez G; Gavilán J
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():217-23. PubMed ID: 27497418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
    Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
    J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
    Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
    J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
    Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint pain and falls among women with breast cancer on aromatase inhibitors.
    Basal C; Vertosick E; Gillis TA; Li Q; Bao T; Vickers A; Mao JJ
    Support Care Cancer; 2019 Jun; 27(6):2195-2202. PubMed ID: 30306326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
    Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
    BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.
    Shanmugam VK; McCloskey J; Elston B; Allison SJ; Eng-Wong J
    Breast Cancer Res Treat; 2012 Jan; 131(2):699-708. PubMed ID: 22076476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
    Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nordic Walking as an Exercise Intervention to Reduce Pain in Women With Aromatase Inhibitor-Associated Arthralgia: A Feasibility Study.
    Fields J; Richardson A; Hopkinson J; Fenlon D
    J Pain Symptom Manage; 2016 Oct; 52(4):548-559. PubMed ID: 27265816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
    Desideri I; Lucidi S; Francolini G; Meattini I; Ciccone LP; Salvestrini V; Valzano M; Morelli I; Angelini L; Scotti V; Bonomo P; Greto D; Terziani F; Becherini C; Visani L; Livi L
    Med Oncol; 2022 Jun; 39(8):113. PubMed ID: 35666314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.